21 CFR § 524.960Chapter I

§ 524.960 Flumethasone, neomycin, and polymyxin B ophthalmic solution.

Primary source

Verbatim text below is from the Electronic Code of Federal Regulations (eCFR), a public-domain U.S. government work. Always verify the current version with the eCFR before relying on it for any legal matter.

Full Text

Specifications.(a) Each milliliter of ophthalmic preparation contains 0.10 milligram flumethasone, 5.0 milligrams neomycin sulfate (3.5 milligrams neomycin base), and 10,000 units of polymyxin B sulfate, with or without hydroxypropyl methylcellulose.

Sponsor.(b) See No. 054771 in § 510.600(c) of this chapter.

Conditions of useAmountPreparation containing hydroxypropyl methylcellulose.(c) —(1) —(i) Dogs: 1 to 2 drops per eye, every 6 hours.

Preparation without hydroxyproply methylcellulose.(ii) Dogs and cats: 2 to 3 drops per eye, every 4 hours.

Indications for use.(2) Treatment of the inflammation, edema, and secondary bacterial infections associated with topical ophthalmological conditions of the eye such as corneal injuries, incipient pannus, superficial keratitis, conjunctivitis, acute nongranulomatous anterior uveitis, kerato- conjunctivitis, and blepharitis.

Limitations.(3) Federal law restricts this drug to use by or on the order of a licensed veterinarian.

[44 FR 16012, Mar. 16, 1979, as amended at 61 FR 5507, Feb. 13, 1996; 79 FR 10968, Feb. 27, 2013]

eCFR data current as of: June 10, 2026

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.